文献速递中毒与环境急症心脑血管急症重症综合管理与镇静镇痛

急性中毒中的心脏毒性与心律失常:一项十年队列研究

Cardiac toxicity and dysrhythmias in acute poisoning: a ten-year cohort study.
PubMed 文献 · Clin Toxicol (Phila) · 2026-10-30
一句话结论急性中毒心脏并发症约5%,以低血压或单纯窦性心动过缓为主,恶性室性心律失常仅0.06%,直接死于中毒相关原发心律失常罕见。

该回顾性分析基于前瞻性维护的临床毒理学数据库,纳入10年间由专科毒理服务管理的9743例急性中毒就诊者。心脏并发症定义为低血压(收缩压<90 mmHg)或与中毒时间相关的原发心律失常(排除窦性心动过速)。心脏并发症发生473例(4.9%),其中低血压368例(3.8%),原发心律失常164例(1.7%),两者兼有59例(0.6%)。原发心律失常以孤立性心动过缓为主(139/164,85%),常与可乐定(40%)及β受体阻滞剂/钙通道阻滞剂中毒(35%)相关;仅25例(0.3%)出现原发心律失常,室性心律失常6例(0.06%),恶性室性心律失常与索他洛尔、美沙酮、艾司西酞普兰、度硫平、去甲替林中毒相关。

要点

  • 急性中毒就诊者中心脏并发症约4.9%,其中低血压3.8%、原发心律失常1.7%,两者兼有0.6%。
  • 原发心律失常以孤立性心动过缓为主(85%),常与可乐定(40%)及β受体阻滞剂/钙通道阻滞剂中毒(35%)相关。
  • 临床显著的原发心律失常仅0.3%,室性心律失常仅0.06%(6例),恶性室性心律失常与索他洛尔、美沙酮、艾司西酞普兰、度硫平、去甲替林相关。
  • 在未选择的急性中毒人群中,临床显著的室性心律失常不常见,支持既往研究结论。

适用人群与场景

  • 由专科毒理服务管理的急性中毒就诊者,纳入10年期间的前瞻性数据库记录。

诊断标准与关键阈值

  • 心脏并发症定义:低血压(收缩压<90 mmHg)或与中毒时间相关的原发心律失常;窦性心动过速被排除。
  • 原发心律失常分类包括:房性心律失常(3例)、传导异常/延迟(10例)、异位心律(5例)、心脏停搏(1例)、室性心律失常(6例)。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 低血压(收缩压<90 mmHg)或原发心律失常(排除窦性心动过速)视为心脏并发症,需按中毒相关心脏毒性处理。
  • 恶性室性心律失常与索他洛尔、美沙酮、艾司西酞普兰、度硫平、去甲替林中毒相关,需警惕。

研究设计与关键结果

  • 研究类型:回顾性分析前瞻性维护的临床毒理学数据库,单中心(原文未明确中心数),10年期间。
  • 样本量:9743例急性中毒就诊。
  • 主要终点:心脏并发症473例(4.9%);低血压368例(3.8%),原发心律失常164例(1.7%),两者兼有59例(0.6%)。
  • 原发心律失常中孤立性心动过缓139/164(85%),与可乐定(40%)及β受体阻滞剂/钙通道阻滞剂中毒(35%)相关。
  • 仅25例(0.3%)出现原发心律失常;室性心律失常6例(0.06%),恶性室性心律失常与索他洛尔、美沙酮、艾司西酞普兰、度硫平、去甲替林相关。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(基于前瞻性维护数据库)。
  • 局限:回顾性分析,单中心(原文未明确中心数),样本来自专科毒理服务,可能不适用于未选择人群。

对床旁实践的改变

  • 急性中毒患者心脏并发症总体约5%,以低血压或孤立性心动过缓为主,应重点识别和处理这两类情况。
  • 临床显著的室性和室上性心律失常少见(<0.3%),在未选择中毒人群中常规强化抗心律失常监测可能收益有限,但原文未直接推荐改变监测策略。
  • 对索他洛尔、美沙酮、三环类抗抑郁药、艾司西酞普兰中毒需警惕室性心律失常,尽管总体罕见。
  • 直接死于中毒相关原发心律失常罕见,预后判断时需综合其他因素。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

INTRODUCTION: Cardiac toxicity is frequently cited as an important cause of morbidity and mortality following acute drug overdose. The true incidence of direct drug related clinically significant cardiac complications and malignant dysrhythmias in more recent toxicology practice remains poorly defined. We aim to determine the frequency, nature, and outcomes of cardiac complications in patients presenting with acute poisoning.

METHODS: We conducted a retrospective analysis of a prospectively maintained clinical toxicology database over a 10-year period. Patients with acute poisoning managed by a specialist toxicology service were included. Cardiac complications were defined as hypotension (systolic blood pressure <90 mmHg) or a primary cardiac dysrhythmia considered temporally related to the poisoning. Sinus tachycardia was excluded. Demographics, exposures, treatments, and outcomes were extracted.

RESULTS: A total of 9,743 poisoning presentations were included. Cardiac complications occurred in 473 patients (4.9%). Hypotension occurred in 368 patients (3.8%), primary dysrhythmias in 164 patients (1.7%), and both hypotension and dysrhythmia in 59 patients (0.6%). Most dysrhythmias were isolated bradycardia (139/164, 85%), commonly associated with clonidine (40%) and beta-blocker/calcium channel blocker poisoning (35%). Only 25 patients (0.3% of all poisoning presentations) developed primary dysrhythmias: atrial dysrhythmias (3), conduction abnormalities/delays (10), ectopic rhythms (5), asystole (1) or ventricular dysrhythmias (6; 0.06%). Malignant ventricular dysrhythmias occurred in six patients and were associated with sotalol, methadone, escitalopram, dothiepin, and nortriptyline poisoning. Twenty-one deaths occurred during the study period, but no death was attributable to a primary dysrhythmia temporally related to poisoning.Discussion: In this large cohort of almost 10,000 poisoning presentations, cardiac complications occurred in approximately one in twenty patients. However, almost 95% of these were either hypotension or isolated bradycardia. Only six patients (0.06%) had ventricular dysrhythmias. Our findings support previous studies demonstrating that clinically significant ventricular dysrhythmias are uncommon among unselected populations presenting with acute poisoning. We found that only a few individual drugs, such as sotalol, methadone, tricyclic antidepressants, and escitalopram, were associated with ventricular dysrhythmias, and that such events were rare overall.

CONCLUSION: Cardiac effects occur in approximately 5% of acute poisoning presentations but are predominantly hypotension or sinus bradycardia. Clinically significant ventricular and supraventricular dysrhythmias are uncommon, occurring in less than 0.3% of cases. Death directly attributable to a primary poisoning-related dysrhythmia is rare.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Berling I, Jenkins S, Isbister GK, et al. Cardiac toxicity and dysrhythmias in acute poisoning: a ten-year cohort study. Clin Toxicol (Phila). 2026. PMID: 42961000. doi:10.1080/15563650.2026.2751594

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。